← Back to Search

Hydrogel

Gelesis200 for Obesity (LIGHT-UP Trial)

N/A
Waitlist Available
Research Sponsored by Gelesis, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to day 171 (week 25)
Awards & highlights

LIGHT-UP Trial Summary

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Assessing the Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects without or with Type 2 Diabetes

Eligible Conditions
  • Obesity
  • Diabetes
  • Prediabetes

LIGHT-UP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to day 171 (week 25)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to day 171 (week 25) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Change in HbA1c
Proportion of subjects with weight loss ≥10.0%
Other outcome measures
Change in BMI
Change in blood pressure
Change in waist circumference
+9 more

LIGHT-UP Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Gelesis200Experimental Treatment1 Intervention
Gelesis200: Three (3) Gelesis200 capsules (2.10 gram (g)) two (2) times per day (id est (i.e.), lunch and dinner)
Group II: PlaceboPlacebo Group1 Intervention
Placebo: Three (3) placebo capsules two (2) times per day (i.e., lunch and dinner)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gelesis200
2016
N/A
~60

Find a Location

Who is running the clinical trial?

Gelesis, Inc.Lead Sponsor
13 Previous Clinical Trials
3,293 Total Patients Enrolled
4 Trials studying Obesity
600 Patients Enrolled for Obesity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes
2017. "Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03058029.
All > Type 2 Diabetes
~37 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top